Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Plos Pathogens|June 30, 2023
α-Synuclein seeding activity in duodenum biopsies from Parkinson's disease patientsSarah Vascellari, Christina D Orrù, Bradley R Groveman, et al.
BMJ Open Respiratory Research|July 30, 2026
Telomere dysfunction and mucociliary impairment drive idiopathic pulmonary fibrosis susceptibility: insights from a Sardinian whole-exome studyStefano Mocci, Roberto Littera, Silvia Deidda, et al.
Clinical and Experimental Medicine|November 6, 2021
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccinationDavide Firinu, Andrea Perra, Marcello Campagna, et al.
Journal of Hepatology|January 19, 2020
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogrammingMarta Anna Kowalik, Elisabetta Puliga, Lavinia Cabras, et al.
Scientific Reports|April 17, 2025
Human leukocyte antigen-G in hepatocellular carcinoma driven by chronic viral hepatitis or steatotic liver diseaseStefano Mocci, Andrea Perra, Roberto Littera, et al.
Frontiers in Immunology|August 13, 2025
The role of HLA-G in primary biliary cholangitis and response to therapyMichela Miglianti, Stefano Mocci, Roberto Littera, et al.
Frontiers in Immunology|June 21, 2023
A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-GStefano Mocci, Roberto Littera, Luchino Chessa, et al.
Hepatology (Baltimore, Md.)|March 4, 2026
The role of OSM/OSMRβ axis in shaping the tumor microenvironment favouring MASLD-Related HCC immune evasionJessica Nurcis, Beatrice Foglia, Chiara Rosso, et al.
Frontiers in Immunology|October 31, 2022
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitisRoberto Littera, Andrea Perra, Michela Miglianti, et al.
Frontiers in Immunology|December 21, 2020
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian ExperienceRoberto Littera, Marcello Campagna, Silvia Deidda, et al.
Pageof 9